Summary
Psychoneuroendocrinology is of major importance in the biological research of depression. Most studies have focussed on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis but other endocrine systems such as the hypothalamic-pituitary-thyroid (HPT), hypothalamic-pituitary-somatotropic (HPS), and the hypothalamic-pituitary-gonadal (HPG) axis have also been shown to be involved in the psychobiology of depression. There are close interrelations between various endocrine axes which possibly are affected during depressive illness.
A variety of neuroendocrine abnormalities has been detected in depressive disorder but the pathophysiology of these derangements remains still unclear. Although the currently used neuroendocrine tests are not of diagnostic validity they may help to clarify the pathophysiological significance of the complex regulatory mechanisms of different neuroendocrine axes in affective disorders. Neuroendocrine regulation is determined both by peripheral and central mechanisms which both have to be adequately considered as well as potent interactions between various endocrine systems in further neuroendocrine depression research.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abramowitz ES, Baker AH, Fleischer SF (1982) Onset of depressive psychiatric crisis and the menstrual cycle. Am J Psychiatry 139: 475–478
Amsterdam JD, Winokur A, Caroff S, Synder P (1981) Gonadotropin release after administration of GnRH in depressed patients and healthy volunteers. J Affective Dis 3: 367–380
Amsterdam JD, Winokur A, Lucki I, Synder P (1983) Neuroendocrine regulation in depressed postmenopausal women and healthy subjects. Acta Psychiatr Scand 67: 43–49
Arana GW, Baldessarini RJ, Ornsteen M (1985) The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiatry 42: 1193–1204
Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB (1987) CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 144: 873–877
Beck-Friis J, Ljunggren JG, Thoren M, v Rosen D, Kjellman BF, Wetterberg L (1985) Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology 10: 173–186
Beckmann H, Holzmüller B, Fleckenstein P (1984) Clinical investigations into antidepressive mechanisms: dexamethasone suppression test predicts response to nomifensine or amitriptyline. Acta Psychiatr Scand 70: 342–353
Berger M, Klein HE (1984) Der Dexamethason Suppressionstest: Ein biologischer Marker der endogenen Depression? Eur Arch Psychiatr Neurol Sci 234: 137–146
Berger M, Pirke KM, Doerr P, Krieg JC, Zerrssen D (1984) The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br J Psychiatry 145: 372–382
Brambilla F, Smeraldi E, Sachetti E, Negri F, Cocchi D, Muller EE (1978) Deranged anterior pituitary responsiveness to hypothalamic hormones in depressed patients. Arch Gen Psychiatry 35: 1231–1238
Brown WA, Shuey I (1979) Response to dexamethasone and subtype of depression. Arch Gen Psychiatry 37: 747–751
Carr DB, Wool C, Lydiard B, Fisher J, Gelenberg A, Klerman G (1984) Rate-sensitive inhibition of ACTH release in depression. Am J Psychiatry 141: 590–592
Carroll BJ (1982) The dexamethasone suppression test for melancholia. Br J Psychiatry 140: 292–304
Carroll BJ, Martin FI, Davis BM (1968) Resistance to suppression by dexamethasone of plasma 11-OHCS levels in severe depressive illness. Br Med J 3: 285–287
Carroll BJ, Greden JF, Feinberg M (1980) Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression. Psychiatry Res 2: 251–258
Carroll BJ, Schroeder K, Mukopadhyay S, Greder JF, Feinberg M, Ritchie J, Tarika J (1980) Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression. J Clin Endocrinol Metab 51: 433–437
Ceulemans DLS, Westenberg, HGM, van Praag HM (1985) The effect of stress on the dexamethasone suppression test. Psychiatry Res 14: 189–195
Cohen MR (1983) Prolactin studies in normals: implications for clinical research. Psychiatry Res 8: 299–310
Dommisse CS, Hayes PE, Kwentus JA (1985) Effect of estrogens on the dexamethasone suppression test in nondepressed women. J Clin Psychopharmacol 5: 315–319
Drago F, Wiegant VM, Sapienza G, Aguglia E, Rapisarda V, Scapargnini (1982) Mianserin reduces plasma levels ofβ-endorphin immunoreactivity in depressed patients. Experientia 38: 685–686
Earle BV (1970) Thyroid hormone and tricyclic antidepressants in resistant depressions. Am J Psychiatry 126: 143–145
Ettigi PG, Brown GM, Seggie JA (1979) TSH and LH response in subtypes of depression. Psychosom Med 41: 203–208
Fang VS, Tricou BJ, Robertson A, Meltzer HY (1981) Plasma ACTH and cortisol levels in depressed patients: relation to the dexamethasone suppression test. Life Sci 29: 931–938
Feighner JP, King LJ, Schuckit MA, Croughan J, Briscoe W (1972) Hormonal potentiation of imipramine and ECT in primary depression. Am J Psychiatry 128: 1230–1238
Frochtengarten ML, Villares JCB, Maluf E, Carlini EA (1987) Depressive symptoms and the dexamethasone suppression test in parkinsonian patients. Biol Psychiatry 22: 386–389
Gibbons JL (1964) Cortisol secretion rate in depressive illness. Arch Gen Psychiatry 10: 572–575
Gormley GJ, Lowy MT, Reder AT, Hospelhorn VG, Antel JP, Meltzer HY (1985) Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test. Am J Psychiatry 142: 1278–1284
Govoni S, Pasinetti G, Inzoli MR, Rozzini R, Trabucchi M (1984) Correlation betweenβ-endorphin/β-lipotropin-immunoreactivity and cortisol plasma concentrations. Life Sci 35: 2549–2552
Graham PM, Booth H, Boranga G, Galhenage S, Myers CM, Teoh CL, Cox LS (1982) The dexamethasone suppression test in mania. J Affective Disord 4: 201–211
Greden JF, Kronfol Z, Gardner R, Feinberg M, Carroll BJ (1981) Neuroendocrine evaluation of schizoaffectives with the dexamethasone suppression test. Biol Psychiatry 16: 461–464
Greden JF, Gardner R, King D, Grunhaus L, Kronfol Z, Carroll BJ (1983) Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch Gen Psychiatry 40: 493–500
Halbreich U, Grunhaus L, Ben-David M (1979) 24-hour rhythm of prolactin in depressive patients. Arch Gen Psychiatry 36: 1183–1186
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62
Haskett RF (1985) Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am J Psychiatry 142: 911–916
Hershman JM, Pardridge WM, Nicoloff JT (1983) Thyroid function in nonthyroidal illness. Ann Intern Med 98: 946–947
Holsboer F, Doerr HG, Sippell WG (1982) Dexamethasone suppression of 11-deoxycorticosterone, corticosterone and cortisol in depressed female patients and normal controls. Acta Psychiatr Scand 66: 18–25
Holsboer F, Benkert O, Demisch L (1983) MAO activity during estrogen treatment of females with endogenous depression. Mod Probl Pharmacopsychiatry 19: 321–326
Holsboer F, Doerr HG, Gerken A, Müller OA, Sippell WG (1984) Cortisol, 11-deoxycortisol, and ACTH concentrations after dexamethasone in depressed patients and healthy volunteers. Psychiatry Res 11: 15–23
Holsboer F, Wiedemann K, Boll E (1986) Shortened dexamethasone half-life time in depressed nonsuppressors. Arch Gen Psychiatry 43: 813–815
Imura H (1985) ACTH and related peptides: molecular biology, biochemistry and regulation of secretion. Clin Endocrinol Metab 14: 845–886
Judd LL, Rish SC, Parker DC, Janowski D, Segal D, Huey L (1982) Blunted prolactin response-neuroendocrine abnormality manifested by depressed patients. Arch Gen Psychiatry 39: 1413–1416
Joyce PR, Donald RA, Livesey JH (1985) A relationship between prolactin levels and the dexamethasone suppression test in major depressive disorder. J Affective Disord 8: 191–195
Kärkkäinen J, Laatikainen T, Naukkarinen H, Salminen K, Spoov J, Stenman U-H, Rimon R (1987) Plasma endogenous opioids and dexamethasone suppression test in depression. Psychiatry Res 21: 151–159
Kalin NH, Weiler SJ, Shelton SE (1982) Plasma ACTH and cortisol concentrations before and after dexamethasone. Psychiatry Res 7: 87–92
Kalin NH, Dawson G, Tariot P, Shelton S, Barksdale C, Weiler S, Thienemann M (1987) Function of the adrenal cortex in patients with major depression. Psychiatry Res 22: 117–125
Klein HE, Seibold B, Bender W, Nedopil N, Albus M, Schmauss M (1984) Postdexamethasone prolactin and cortisol: a biological state variable in depression. Acta Psychiatr Scand 70: 239–247
Klein HE, Bender W, Mayr H, Niederschweiberer A, Schmauss M (1984) The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome. Br J Psychiatry 145: 591–599
Krantz DE, Brown WA (1985) Dexamethasone suppresses beta-endorphin in humans. Psychoneuroendocrinology 10: 211–214
Kroll P, Palmer C, Greden JF (1983) The dexamethasone suppression test in patients with alcoholism. Biol Psychiatry 18: 441–450
Lesch KP, Laux G, Schulte HM, Pfüller H, Beckmann H (1988) Corticotropin and cortisol response to human corticotropin releasing hormone as a probe for hypothalamic-pituitary-adrenal system integrity in major depressive disorder. Psychiatry Res 24: 25–34
Lesch KP, Rupprecht R (1989) Psychoneuroendocrine research in depression II: hormonal response to releasing hormones as a probe for hypothalamic-pituitary-endorgan dysfunction. J Neural Transm 75: 179–194
Linkowski P, Mendlewicz J, Leclercq R, Brasseur M, Hubain P, Golstein J, Copinschi G, van Cauter E (1985) The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 61: 429–438
Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Golstein J, Brasseur M, Copinschi G, van Cauter E (1987) 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 65: 141–152
Linnoila M, Lamberg BA, Rosberg G, Karonen SL, Welin MG (1979) Thyroid hormones and TSH, prolactin and LH responses to repeated TRH and LRH injections in depressed patients. Acta Psychiatr Scand 59: 536–544
Linnoila M, Cowdry R, Bror-Axel L, Makinen T, Rubinow D (1983) CSF triiodothyronine (rT3) levels in patients with affective disorders. Biol Psychiatry 18: 1489–1492
Lisansky J, Fava GA, Buckman MT, Kellner R, Fava M (1984) Prolactin, amitryptiline and recovery from depression. Psychopharmacology 84: 331–335
Lowy MT, Meltzer HY (1987) Dexamethasone bioavailability: implications for DST research. Biol Psychiatry 22: 373–385
Lypka A, Szcdulik A (1985) Dexamethasone suppresses cortisol but not ACTH andβ-endorphin plasma concentrations in healthy man. Hormon Metab Res 17: 547
Meador-Woodruff JH, Haskett RF, Grunhaus L, Akil H, Watson SJ, Greden JF (1987) Postdexamethasone plasma cortisol andβ-endorphin levels in depression: relationship to severity of illness. Biol Psychiatry 22: 1137–1150
Meltzer HY, Fang VS, Tricou BJ, Robertson A, Piyaka SK (1982) Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients. Am J Psychiatry 139: 763–769
Mendlewicz J, van Cauter E, Linkowsky P, L'Hermite M, Robyn C (1980) The 24-hour profile of prolactin in depression. Life Sci 27: 2015–2024
Mendlewicz J, Charles G, Franckson JM (1982) The dexamethasone suppression test in affective disorder: Relationship to clinical and genetic subgroups. Br J Psychiatry 141: 464–470
Morris H, Carr V, Gilliland J, Hooper M (1986) Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders. Br J Psychiatry 148: 66–69
Munro JG, Hardiker TM, Leonard DP (1984) The dexamethasone suppression test in residual schizophrenia with depression. Am J Psychiatry 141: 250–252
Myers ED (1984) Serial dexamethasone suppression tests in male chronic schizophrenic patients. Am J Psychiatry 141: 904–905
Naber D, Pickar D, Post RM, v Kammen DP, Walters RN, Ballenger JC, Goodwin FK, Bunney WD (1981) Endogenous opioid activity andβ-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. Am J Psychiatry 138: 1457–1462
Nagel J, Tegeler J, Goertz B (1982) Serum Konzentrationen desβ-Endorphins bei schizophrenen und depressiven Erkrankungen. Nervenarzt 62: 659–663
Nasr SJ, Rodgers C, Pandey G, Altmann EG, Gaviria FM, Davies JM (1983) ACTH and the dexamethasone suppression test in depression. Biol Psychiatry 18: 1069–1073
Nemeroff JB, Widerlöv E, Bisette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen P, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing-factor-like immunoreactivity in depressed patients. Science 226: 1342–1343
Norman TR, Piperoglou M, McIntyre I, Lynch C, Burrows GD (1987) Plasma immunoreactiveβ-endorphin in dexamethasone suppressors and non-suppressors of cortisol. J Affective Disord 12: 233–239
Orsulak PJ, Crowley G, Schlesser MA, Giles D, Fairchild C, Rush AJ (1985) Free triiodothyronine (T3) and thyroxine (T4) in a group of unipolar depressed patients and normal subjects. Biol Psychiatry 20: 1047–1057
Pfohl B, Sherman B, Schlechte J, Winokur G (1985) Differences in plasma ACTH and cortisol between depressed patients and normal controls. Biol Psychiatry 20: 1055–1072
Prange AL, Loosen PT, Wilson IC, Lipton MA (1984) The therapeutic use of hormones of the thyroid axis in depression. In: Post RM, Ballenger JC (eds) Neuroendocrinology. Williams & Wilkins, Baltimore, pp 311–322
Reus VI, Joseph MS, Dallman MF (1982) ACTH levels after the dexamethasone suppression test in depression. N Engl J Med 306: 238–239
Rish SC (1982)β-endorphin hypersecretion in depression: possible cholinergic mechanisms. Biol Psychiatry 17: 1071–1079
Roy A, Gold P, Pickar D, Wolkowitz OM, Chrousos G, Paul SM (1986) Pre- and post-dexamethasone ACTH levels in depressed patients and normal controls. J Affective Disord 10: 95–99
Rubin RT, Poland RE, Blodgett ALN, Winston RA, Forster B, Carroll BJ (1980) Cortisol dynamics and dexamethasone pharmacokinetics in primary endogenous depression: preliminary findings. In: Brambilla F, Racagni G, de Wied D (eds) Progress in psychoneuroendocrinology. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 223–234
Rubin RT, Poland RE, Tower BB, Hart PA, Blodgett ALN, Forster B (1981) Hypothalamo-pituitary-gonadal function in primary endogenously depressed men: preliminary findings. In: Fuxe K, Gustafsson JA, Wetterberg L (eds) Steroid hormone regulation of the brain. Pergamon Press, Oxford, pp 387–396
Rupprecht R, Barocka A, Jecht E, Noder M, Pichl J, Schwarz W (1987) Prolactin response to dexamethasone: a study on normal controls and depressed patients. Acta Psychiatr Scand 76: 139–143
Rupprecht R, Noder M, Jecht E, Rupprecht C, Rupprecht M, Schwarz W, Diepgen T (1988) Pre- and postdexamethasone cortisol and prolactin levels in sexual dysfunction and normal controls. Biol Psychiatry 23: 527–530
Rupprecht R, Barocka A, Beck G, Schrell U, Pichl J (1988) Pre- and postdexamethasone plasma ACTH andβ-endorphin levels in endogenous and non-endogenous depression. Biol Psychiatry 23: 531–535
Rupprecht R, Noder M, Jecht E, Schwarz W, Rupprecht C, Rupprecht M, Diepgen T (1988) Gonadal steroid and gonadotropin response to dexamethasone: a study in sexual dysfunction and normal controls. J Neural Transm 71: 227–234
Rupprecht R, Rupprecht C, Rupprecht M, Noder M, Mahlstedt J (1988) Triiodothyronine, thyroxine and TSH response to dexamethasone in depressed patients and normal controls. Biol Psychiatry (in press)
Sachar EJ, Hellman L, Fukashima DK (1970) Cortisol production in depressive illness: a clinical and biochemical classification. Arch Gen Psychiatry 23: 289–298
Sachar EJ, Halpern F, Rosenfeld RS, Gallagher TF, Hellman L (1973) Plasma and urinary testosterone levels in depressed men. Arch Gen Psychiatry 28: 15–18
Sachar EJ, Hellmann L, Roffwarg H, Halpern F, Fukushima DK, Gallagher D (1973) Disrupted 24-hour patterns of cortisol secretion in psychogenic depression. Arch Gen Psychiatry 28: 19
Saleem PT (1984) Dexamethasone suppression test in depressive illness: its relation to anxiety symptoms. Br J Psychiatry 144: 181–184
Sangal R, Correa El, DePaulo JR (1984) Depression and anxiety inventories and the dexamethasone suppression test. Biol Psychiatry 19: 1207–1213
Schlechte JA, Sherman B (1985) Lymphocyte glucocorticoid receptor binding in depressed patients with hypercortisolemia. Psychoneuroendocrinology 10: 469–474
Spar JE, Gerner R (1982) Does the dexamethasone suppression test distinguish dementia from depression? Am J Psychiatry 139: 238–240
Spratt DI, Pont A, Miller MB (1982) Hyperthyroxinemia in patients with acute psychiatric disorders. Am J Med 73: 41–47
Stokes PE, Pick GR, Stoll PM (1975) Pituitary adrenal function in depressed patients: resistance to dexamethasone suppression. J Psychiatry Res 12: 271–281
Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E (1985) (letter). Arch Gen Psychiatry 42: 202–204
Svec F, Rudis M (1981) Glucocorticoids regulate the giucocorticoid receptor in the AtT-20 cell. J Biol Chem 256: 5984–5987
Tornello S, Orti E, De Nicola AF (1982) Regulation of glucocorticoid receptors in brain by corticosterone treatment of adrenalectomized rats. Neuroendocrinology 35: 411–417
Unden F, Ljunggren J-G, Kjellman BF, Beck-Friis J, Wetterberg L (1986) Twenty-four-hour serum levels and decreased TSH response to TRH in affective disorders. Acta Psychiatr Scand 73: 358–365
Vogel W, Klaiber EL, Broverman DM (1978) Roles of the gonadal steroid hormones in psychiatric depression in men and women. Prog Neuropsychopharmacol 2: 487–503
Whalley LJ, Borthwick N, Copolov D, Dick H, Christie JE, Fink G (1986) Glucocorticoid receptors and depression. Br Med J 292: 859–861
Yerevanian BI, Olafsdottir H, Milanese E, Russotto J, Mallon P, Baciewicz G, Sagi E (1983) Normalization of the dexamethasone suppression test at discharge from hospital. J Affective Disord 5: 191–197
Yerevanian BI, Woolf PD, Iker HP (1983) Plasma ACTH levels in depression before and after recovery: relationship to the dexamethasone suppression test. Psychiatry Res 10: 175–181
Yesavage JA, Davidson J, Widrow L, Berger PA (1985) Plasma testosterone levels, depression, sexuality and age. Biol Psychiatry 20: 222–225
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rupprecht, R., Lesch, K.P. Psychoneuroendocrine research in depression. J. Neural Transmission 75, 167–178 (1989). https://doi.org/10.1007/BF01258628
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01258628